Navigation Links
Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
Date:8/13/2008

BEIJING, Aug. 13 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Monday, August 18, 2008 to discuss results for the quarter ended June 30, 2008.

To participate in this live conference call, please dial 888-339-2688 five to ten minutes prior to the scheduled conference call time. International callers should dial 617-847-3007. The conference Passcode is 899 273 89.

For those who are unable to participate in the conference call at the time of the call, a replay will be available for fourteen days starting on August 18, at 10:00 a.m. Eastern Time. To access the replay, please dial 888-286- 8010. International callers should dial 617-801-6888. The replay Passcode is 522 821 17.

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development, distribution and sales of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

Forward Looking Statements

Certain statements set forth in this press release constitute "Forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the wor
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
2. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
3. Yongye Biotechnology International Retains CCG Investor Relations
4. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
5. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
6. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
7. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
8. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
9. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
10. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
11. Leading Biotechnology Company Grows with StayinFront CRM

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).../PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corpor...pany"), today announced,financial results for the ...ird Quarter 2009 Financial Highlights Include:, ...million in the prior year, period, reflectin... licensed products;, -- Gross margin increas...
(Date:11/9/2009)... 9 For more than 20 years,research...velopment of a,Brain-Computer Interface (BCI). Thi...ain and a computer. Such a system enables complete... devices in their environment just by,mental activ... supervised by,the researchers themselves to use s...
(Date:11/9/2009)...e is a research industry first, allowing veterinar...rch safety study data to be managed in one softwar...olls, NJ (PRWEB) November 9, 2009 -- Xybion Medica...stima™ VM, an integrated enterprise software...se and care of veterinary research subjects. Prist...
(Date:11/6/2009)...all/ - Microbix Biosystems Inc. (the "Company") an...F1 Certification of Annual Filings of William Gast...e Chief Financial Officer (the "Officer,s Certific...he annual audited financial statements for the yea...ially filed the annual financial statements for th...
Breaking Biology Technology:BMP Sunstone Reports Third Quarter 2009 Financial Results 2BMP Sunstone Reports Third Quarter 2009 Financial Results 3BMP Sunstone Reports Third Quarter 2009 Financial Results 4BMP Sunstone Reports Third Quarter 2009 Financial Results 5BMP Sunstone Reports Third Quarter 2009 Financial Results 6BMP Sunstone Reports Third Quarter 2009 Financial Results 7BMP Sunstone Reports Third Quarter 2009 Financial Results 8BMP Sunstone Reports Third Quarter 2009 Financial Results 9BMP Sunstone Reports Third Quarter 2009 Financial Results 10BMP Sunstone Reports Third Quarter 2009 Financial Results 11BMP Sunstone Reports Third Quarter 2009 Financial Results 12intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2
...rnerstone Therapeutics Inc. (Nasdaq: CRTX ), a s...ng, developing and commercializing significant pro...reported financial results for the year ended Dece... Full-Year 2008 Net Revenues more than doubled... , , , Income from Operations increased...
... A recent study using state-of-the-art genetic tes...alled Ambra-Lift™ by Elina™ Organic...til now only Resveratrol, a substance found in the...turally stimulate Sirtuin-1 in humans. Ambra-Lift... Kalamazoo, MI (PRWEB) March 26, 2009 -- ...
...PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.,...outsourcing company serving the,pharmaceutical, bi...perations,in China and the United States, today an...nd full-year 2008. , (Logo: http://www.newscom...ights, -- Total Company(1) Full-Year 2008 Net R...
Other Biology Technology:Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 2Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 3Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 4Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 5Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 6Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 7Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 8Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 9Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 10Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 11Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 12Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene 2Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene 3Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 20
(Date:11/9/2009)... 9 CBS Vision, the research divisi...nicom Media Group company, today announced a new r...access to the CBS Television City research facilit..., The new venture, which marries the capabilities...encies, will be called Communications Lab@OMD . ,...
(Date:11/9/2009)...tion method that begins by soaking corn kernels ra...f ethanol and more usable co-products, giving etha...ut 20 percent. , "The conventional ethanol produ...llers dried grains with soluble, it doesn,t have a... Agricultural Engineer Esha Khullar. "Whereas in b...
(Date:11/9/2009)...r, the hopeful news is that pediatric survival rat...ad newstreatments that enable survival often cause... have reached puberty currently have an opportunit...ancer treatment, they may have their semen frozen ...r, do not produce sperm, although their testicular...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Wet ethanol production process yields more ethanol and more co-products 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3For OCD Not Helping Might Be Best 50750 1For OCD Not Helping Might Be Best 50750 2Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention 50745 1Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention 50745 2Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 1Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 2
...ic fungi as model systems for understanding fungal... new work that offers insight into how carbon diox...ow pathogenic fungi to survive in different enviro... new evidence for how CO2 sensing and metabolism u... the growth and sexual reproduction of pathogenic ...
...lication of an fMRI (functional magnetic resonance... of Pennsylvania School of Medicine have, for the ...chological stress in a healthy human brain. , Thei...Neuroimaging, provides a neuro-imaging marker of p... the development of improved strategies for preven...
...ience fiction, but New Mexico State University res...ogy on cattle as part of a national tracking syste...a growing technological trend in cattle identifica...t NMSU,s Clayton Livestock Research Center. "It pa...and records the pattern of veins in the eye." , E...
Other Biology News:CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts 2CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts 3Research Permits First-Ever Visualization of Psychological Stress in the Human Brain 2Retinal scans eyed for New Mexico show cattle 2Retinal scans eyed for New Mexico show cattle 3
Nar I from Promega
Chicken Anti-UCK2 Polyclonal Antibody, Unconjugated from Abcam
...nant Enterokinase (rEK) is a highly purified prepa...nase, a serine protease which recognizes the ident...AspLys↓) and has similar enzymatic activity. ...ified to yield the highest activity available, and...
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: